Jianmin Duan, PhD, is an experienced pharmaceutical research and development scientist with expertise in drug absorption, distribution, metabolism, excretion, pharmacokinetics and pharmacology. He has excelled as a well-respected consultant to pharmaceutical and biotechnology companies in guiding R&D evaluations, regulatory submissions, implementing and validating novel biological assays, CMC, experimental design, data analysis, formulation design, cross-species predictions, and selecting and implementing PK/PD/Tox models to inform drug development decisions.
Dr. Duan spent more than 20 years at Boehringer Ingelheim (Canada) Ltd. in roles of increasing responsibility, most recently as Director, Preclinical ADMEPK/Pharmacology
He has authored more than 50 papers that have appeared in peer-reviewed journals and holds three patents.
